Xylocaine 1% Inj, 50ml

Manufacturer APP Active Ingredient Lidocaine Injection Solution (Anesthetic)(LYE doe kane) Pronunciation LYE doe kane
It is used to numb an area before a procedure.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Local Anesthetic, Antiarrhythmic
đŸ§Ŧ
Pharmacologic Class
Voltage-gated sodium channel blocker, Class IB Antiarrhythmic
🤰
Pregnancy Category
Category B
✅
FDA Approved
Sep 1948
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Lidocaine is a medication used to numb a specific area of your body, preventing you from feeling pain during medical procedures like stitches, minor surgery, or dental work. It works by temporarily blocking nerve signals in the area where it's injected.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and adhere to all provided guidelines. This medication is administered via injection.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage method.

If you miss a dose, contact your doctor promptly to receive guidance on the appropriate course of action.
💡

Lifestyle & Tips

  • Report any unusual sensations (e.g., dizziness, ringing in ears, numbness around mouth, muscle twitching) immediately during or after the injection.
  • Avoid touching or putting pressure on the numb area until sensation returns, to prevent accidental injury.
  • Follow post-procedure instructions carefully, especially regarding activity restrictions or wound care, as the numbing effect may mask pain.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Varies significantly by procedure and site of administration. For infiltration anesthesia: 5-300 mg (0.5-30 mL of 1% solution). For peripheral nerve block: 50-300 mg (5-30 mL of 1% solution). Max single dose: 4.5 mg/kg (not to exceed 300 mg) without epinephrine, or 7 mg/kg (not to exceed 500 mg) with epinephrine.
Dose Range: 5 - 500 mg

Condition-Specific Dosing:

infiltration_anesthesia: 5-300 mg (0.5-30 mL of 1% solution)
peripheral_nerve_block: 50-300 mg (5-30 mL of 1% solution)
epidural_anesthesia: 200-300 mg (20-30 mL of 1% solution)
caudal_anesthesia: 150-300 mg (15-30 mL of 1% solution)
maximum_single_dose_without_epinephrine: 4.5 mg/kg (not to exceed 300 mg)
maximum_single_dose_with_epinephrine: 7 mg/kg (not to exceed 500 mg)
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for routine use; use with extreme caution. Max dose: 2-4 mg/kg.
Infant: Max dose: 2-4 mg/kg (single dose).
Child: Max dose: 2-4 mg/kg (single dose), not to exceed 4.5 mg/kg or 300 mg total. Lower concentrations (0.5% or 1%) are preferred.
Adolescent: Max dose: 2-4 mg/kg (single dose), not to exceed 4.5 mg/kg or 300 mg total. Lower concentrations (0.5% or 1%) are preferred.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment typically required for single dose local anesthesia.
Moderate: No specific adjustment typically required for single dose local anesthesia.
Severe: Use with caution. Accumulation of lidocaine and its metabolites may occur. Consider lower doses and extended intervals, especially with repeated administration.
Dialysis: Lidocaine is minimally dialyzable. Use with caution; consider lower doses.

Hepatic Impairment:

Mild: Use with caution. Consider lower doses.
Moderate: Reduce dose by 50% or more. Monitor for signs of toxicity. Lidocaine clearance is significantly reduced.
Severe: Contraindicated or use with extreme caution and significant dose reduction (e.g., 75% reduction). Monitor closely for toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby exerting a local anesthetic action. It blocks voltage-gated sodium channels in the neuronal cell membrane, preventing the influx of sodium ions and thus inhibiting depolarization and propagation of action potentials.
📊

Pharmacokinetics

Absorption:

Bioavailability: Varies greatly depending on site of administration, presence of vasoconstrictor (epinephrine), dosage, and vascularity of the tissue. Systemic absorption is rapid from highly vascularized sites (e.g., intercostal block) and slower from subcutaneous tissue.
Tmax: Variable (e.g., 5-15 minutes for intercostal block, 30-90 minutes for epidural block).
FoodEffect: Not applicable for injectable formulation.

Distribution:

Vd: 0.7-2.7 L/kg (average 1.1 L/kg) in healthy adults. Higher in patients with heart failure or renal failure.
ProteinBinding: 60-80% (primarily to alpha-1-acid glycoprotein and albumin). Binding is concentration-dependent and decreases with increasing concentration.
CnssPenetration: Yes (readily crosses blood-brain barrier and placenta).

Elimination:

HalfLife: 1.5-2 hours (prolonged in hepatic impairment, heart failure, and in neonates).
Clearance: Approximately 10 mL/min/kg.
ExcretionRoute: Renal (less than 10% as unchanged drug).
Unchanged: Less than 10%
âąī¸

Pharmacodynamics

OnsetOfAction: 2-5 minutes (infiltration), 5-15 minutes (nerve block, epidural).
PeakEffect: Variable, often within 10-30 minutes depending on site.
DurationOfAction: 30-60 minutes (infiltration without epinephrine), 60-120 minutes (infiltration with epinephrine), 1-3 hours (nerve block, epidural).

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of methemoglobinemia, a rare but potentially deadly condition, such as:
+ Blue or gray discoloration of the lips, nails, or skin
+ Abnormal heartbeat
+ Seizures
+ Severe dizziness or fainting
+ Severe headache
+ Excessive sleepiness
+ Fatigue or weakness
+ Shortness of breath
Signs of acidosis (too much acid in the blood), such as:
+ Confusion
+ Rapid breathing
+ Rapid heartbeat
+ Abnormal heartbeat
+ Severe stomach pain, nausea, or vomiting
+ Excessive sleepiness
+ Shortness of breath
+ Fatigue or weakness
Other severe side effects, including:
+ Breathing difficulties, slow breathing, or shallow breathing
+ Lightheadedness, drowsiness, confusion, or blurred vision
+ Slow heartbeat
+ Nervousness or excitability
+ Speech difficulties
+ Abnormal sensations, such as burning, numbness, or tingling
+ Restlessness
+ Anxiety
+ Changes in vision
+ Ringing in the ears
+ Dizziness or fainting
+ Severe headache
+ Twitching
+ Shakiness
+ Seizures
+ Feeling excessively hot or cold
+ Metallic taste
+ Chest pain
+ Mood changes

If you receive this medication via spinal injection, you may also experience:

Erectile dysfunction
Loss of motor function
Loss of bladder or bowel control
Urination difficulties

Other Possible Side Effects

As with any medication, you may experience side effects. While many people do not experience significant side effects, some may have mild or moderate reactions. If you experience any side effects that bother you or persist, contact your doctor for guidance.

Remember, this is not an exhaustive list of potential side effects. If you have concerns or questions, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Dizziness or lightheadedness
  • Ringing in the ears (tinnitus)
  • Numbness or tingling around the mouth
  • Metallic taste in the mouth
  • Blurred vision or double vision
  • Confusion or disorientation
  • Tremors or muscle twitching
  • Seizures
  • Unusual drowsiness or loss of consciousness
  • Slow or irregular heartbeat
  • Difficulty breathing
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

To ensure safe treatment, inform your doctor of the following:

Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reactions you experienced.
If you are scheduled to receive this medication via spinal injection, tell your doctor if you have:
+ Heart block
+ Severe bleeding
+ Severe infection
+ An infection at the injection site

It is crucial to disclose all your health conditions and medications to your doctor and pharmacist, including:
Prescription and over-the-counter (OTC) medications
Natural products
* Vitamins

This will help determine if it is safe to take this medication with your existing health conditions and other medications. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Risk of Methemoglobinemia
A severe blood condition called methemoglobinemia has been associated with drugs like this one. Your risk may be increased if you have:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Heart problems
- Lung problems
- Are taking certain other medications
- Are an infant younger than 6 months of age
If you have a history of methemoglobinemia, notify your doctor.

Sulfite Allergy
If you are allergic to sulfites, consult your doctor before taking this medication, as some products may contain sulfites.

Caution with Daily Activities
Avoid driving and engaging in activities that require alertness until the effects of this medication have worn off and you feel fully awake.

Post-Treatment Precautions
If you are discharged before the numbness has resolved, protect the treated area from injury until you have regained sensation.

Special Considerations
- If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
- If the patient is a child, use this medication with caution, as the risk of certain side effects may be higher in children.
- If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks with your doctor.

Injection into the Spine
This medication may cause temporary loss of feeling and motor function in the lower half of your body. Do not attempt to get out of bed or perform other activities until sensation and motor function have returned to normal.

Mouth and Dental Procedures
Do not eat while your mouth is numb, as you may inadvertently bite your tongue.
🆘

Overdose Information

Overdose Symptoms:

  • Severe CNS effects (seizures, coma, respiratory arrest)
  • Cardiovascular depression (severe hypotension, bradycardia, arrhythmias, cardiac arrest)

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. For general information, call Poison Control at 1-800-222-1222.

Drug Interactions

🔴

Major Interactions

  • Antiarrhythmics (Class I, e.g., mexiletine, tocainide): Increased risk of cardiac depression and toxicity.
  • Beta-blockers (e.g., propranolol, metoprolol): May decrease hepatic metabolism of lidocaine, leading to increased lidocaine plasma levels and toxicity.
  • Cimetidine: Inhibits hepatic metabolism of lidocaine, increasing plasma levels and risk of toxicity.
  • Other local anesthetics: Additive systemic toxicity.
🟡

Moderate Interactions

  • Phenytoin: May increase lidocaine metabolism; also, phenytoin itself has antiarrhythmic properties.
  • Skeletal muscle relaxants (e.g., succinylcholine): Prolonged neuromuscular blockade.
  • Amide-type local anesthetics (e.g., bupivacaine, ropivacaine): Increased risk of systemic toxicity if administered concurrently or sequentially in large doses.
  • CYP1A2/3A4 inhibitors (e.g., macrolide antibiotics, azole antifungals, protease inhibitors): May increase lidocaine levels.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Allergy history

Rationale: To identify contraindications to lidocaine or other amide-type local anesthetics.

Timing: Prior to administration

Vital signs (heart rate, blood pressure, respiratory rate)

Rationale: To establish baseline and identify pre-existing cardiovascular or respiratory compromise.

Timing: Prior to administration

Patient's general condition and comorbidities (e.g., hepatic/renal impairment, heart failure)

Rationale: To assess risk of toxicity and guide dosing.

Timing: Prior to administration

📊

Routine Monitoring

Vital signs (heart rate, blood pressure, respiratory rate)

Frequency: During and immediately after administration, then as clinically indicated.

Target: Within patient's normal range; monitor for significant deviations.

Action Threshold: Bradycardia, hypotension, hypertension, respiratory depression, or significant changes from baseline.

Signs and symptoms of systemic toxicity (CNS and cardiovascular)

Frequency: Continuously during and for at least 30 minutes after administration, especially with larger doses or highly vascular areas.

Target: Absence of symptoms.

Action Threshold: Lightheadedness, dizziness, tinnitus, perioral numbness, metallic taste, confusion, muscle twitching, seizures, drowsiness, hypotension, bradycardia, arrhythmias.

Level of consciousness

Frequency: Continuously during and after administration.

Target: Alert and oriented.

Action Threshold: Drowsiness, confusion, disorientation, loss of consciousness.

đŸ‘ī¸

Symptom Monitoring

  • Lightheadedness
  • Dizziness
  • Tinnitus
  • Perioral numbness
  • Metallic taste
  • Slurred speech
  • Nystagmus
  • Blurred vision
  • Tremors
  • Muscle twitching
  • Convulsions (seizures)
  • Drowsiness
  • Unconsciousness
  • Hypotension
  • Bradycardia
  • Cardiac arrest
  • Respiratory depression
  • Apnea

Special Patient Groups

🤰

Pregnancy

Lidocaine is generally considered safe for use during pregnancy (Category B). It crosses the placenta but is rapidly metabolized. Use the lowest effective dose.

Trimester-Specific Risks:

First Trimester: No evidence of increased risk of congenital anomalies.
Second Trimester: Generally considered safe.
Third Trimester: Generally considered safe. May cause fetal bradycardia or CNS depression if high maternal plasma levels occur, especially with paracervical block.
🤱

Lactation

Lidocaine is excreted into breast milk in small amounts. It is considered compatible with breastfeeding (L2 - Safer). The amount ingested by the infant is typically very low and rapidly metabolized.

Infant Risk: Low risk of adverse effects to the breastfed infant. Monitor for drowsiness or feeding difficulties, though unlikely.
đŸ‘ļ

Pediatric Use

Children, especially younger ones, are more susceptible to systemic toxicity due to differences in metabolism and higher relative doses per body weight. Use the lowest effective concentration and dose. Max dose: 2-4 mg/kg (without epinephrine). Careful monitoring for signs of toxicity is crucial.

👴

Geriatric Use

Elderly patients may have reduced hepatic function, decreased protein binding, and reduced renal clearance, leading to higher plasma concentrations and increased risk of toxicity. Use lower doses and monitor closely. Consider age-related changes in body composition and organ function.

Clinical Information

💎

Clinical Pearls

  • Always aspirate prior to injection to avoid inadvertent intravascular administration, which can lead to rapid systemic toxicity.
  • The addition of epinephrine prolongs the duration of action and reduces systemic absorption, allowing for higher total doses, but should be avoided in areas with end-arterial circulation (e.g., fingers, toes, nose, ears, penis) due to risk of ischemia.
  • Systemic toxicity typically manifests as CNS symptoms first (e.g., circumoral numbness, tinnitus, lightheadedness, seizures), followed by cardiovascular depression (e.g., hypotension, bradycardia, arrhythmias).
  • Manage systemic toxicity by stopping the injection, ensuring airway patency, administering oxygen, and if severe, managing seizures (e.g., benzodiazepines) and cardiovascular collapse (e.g., IV fluids, vasopressors, lipid emulsion therapy for severe cases).
  • The 1% solution means 10 mg of lidocaine per mL. A 50 mL vial contains 500 mg of lidocaine.
  • Be aware of the maximum recommended doses per kg body weight to prevent toxicity.
🔄

Alternative Therapies

  • Bupivacaine (longer-acting local anesthetic)
  • Ropivacaine (longer-acting local anesthetic, less cardiotoxic than bupivacaine)
  • Mepivacaine (intermediate-acting local anesthetic)
  • Chloroprocaine (short-acting ester-type local anesthetic)
  • Procaine (short-acting ester-type local anesthetic)
💰

Cost & Coverage

Average Cost: Varies widely by supplier and contract per 50mL vial of 1% solution
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (generic); Tier 3 or 4 (brand, if applicable)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, avoid flushing medications down the toilet or pouring them down the drain. If you are unsure about the correct disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the quantity, and the time of the incident.